Delivery Order SPE2DB22D3004-SPE2DB25FSC58
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,820.47 to AmerisourceBergen Drug Corp for the supply of Naloxone HCL 4 mg nasal spray on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order represents a non-set-aside award, indicating it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Naloxone is a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Naloxone HCL 4 mg nasal spray with a ceiling value of $8,699.87. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for completion by June 3, 2025, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Naloxone is a critical opioid...
- The Defense Logistics Agency awarded a delivery order valued at $5,241.60 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, will supply...
- The Defense Logistics Agency awarded a $23,532.89 delivery order to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray on May 16, 2025, with a completion date of May 19, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,124.16 to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray (2-count units) on August 22, 2025, with completion scheduled for August 25, 2025. This firm fixed price contract was awarded competitively with no set-aside designation and is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,928.40 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price, non-set-aside contract is classified as a child award, indicating it derives from a larger contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $10,266.71 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray. This contract, which was competitively awarded with no set-aside designation, has a firm fixed price structure and an ultimate completion date of August 18, 2025. The product will be delivered to a location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $4,507.14 for Naloxone HCL 4 mg nasal spray on September 2, 2025, with completion scheduled for September 3, 2025. This competitively awarded, firm fixed-price delivery order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in open federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,189.90 for Naloxone HCl 4 mg nasal spray on September 26, 2025, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order is not set-aside and will be performed in Conshohocken, Pennsylvania, where the awardee maintains its corporate headquarters. The product represents critical medical supply for overdose reversal, which supports the agency's pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naloxone 4mg nasal spray (2-count units) with a ceiling value of $5,680.80. This competitively awarded, firm fixed-price delivery order was issued on April 24, 2025, with an ultimate completion date of the same day, indicating an expedited fulfillment requirement. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania....
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSC58Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,191.84 to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed price delivery order, which was competitively awarded without set-aside designation, is to be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Naloxone is a critical opioid antagonist medication used in emergency medical response and overdose reversal across military healthcare systems and federal agencies. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement running through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp supplies a broad portfolio of medications and medical supplies to support military healthcare programs globally. The company's federal contract awards demonstrate extensive capability in fulfilling diverse pharmaceutical procurement requirements through open competition, positioning it as a critical vendor for Defense Health Agency and other federal healthcare systems' medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/21/25 |